サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1784172

皮下避妊インプラントの世界市場

Subdermal Contraceptive Implants

出版日
ページ情報
英文 281 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
皮下避妊インプラントの世界市場
出版日: 2025年08月05日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 281 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

皮下避妊インプラントの世界市場は2030年までに16億米ドルに達する

2024年に11億米ドルと推定される皮下避妊インプラントの世界市場は、2024～2030年の分析期間においてCAGR 6.7%で成長し、2030年には16億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるエトノゲストレルインプラントは、CAGR 7.9％を記録し、分析期間終了までに11億米ドルに達すると予想されます。レボノルゲストレルインプラントセグメントの成長率は、分析期間中CAGR 4.6%と推定されます。

米国市場は推定2億9,600万米ドル、中国はCAGR 10.8％で成長予測

米国の皮下避妊インプラント市場は、2024年に2億9,600万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを10.8%として、2030年までに3億3,770万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と6.6％と予測されています。欧州では、ドイツがCAGR 4.5%で成長すると予測されています。

世界の皮下避妊インプラント市場- 主要動向と促進要因まとめ

なぜ皮下インプラントは従来の避妊薬よりも支持を集めているのか？

皮下避妊インプラントの世界の普及が著しいのは、主に生殖年齢の女性の間で長時間作用型可逆的避妊薬（LARC）への嗜好が高まっているためです。毎日の経口避妊薬やパッチや注射のような短期避妊法とは異なり、皮下インプラントは1回の挿入で3～5年間避妊できるため、使用者の誤りのリスクを大幅に軽減し、全体的な有効性を高めることができます。市場は、リプロダクティブ・ライツ（性と生殖に関する権利）と避妊の選択肢に関する認識と教育の向上、特にヘルスケアへのアクセスが改善しつつある新興国市場の恩恵を受けています。さらに、世界保健機関（WHO）、国連人口基金（UNFPA）、米国国際開発庁（USAID）などの組織による公衆衛生への取り組みが、出生率が高く避妊資源へのアクセスが限られている地域でのインプラントの使用を積極的に促進しています。子宮内避妊具（IUD）に比べ、皮下インプラントは侵襲性が低く、子宮に装着する必要がないため、出産経験のない女性にとって好ましい選択肢です。インプラントの最小限のメンテナンス、目立たない性質、可逆的な機能は、避妊の見方を変え、利便性、自律性、長期的な計画へと物語をシフトしています。その結果、こうした避妊器具は、都市部の教育水準の高い人々に支持されているだけでなく、政府やNGOが支援するプログラムを通じて、農村部や十分なサービスを受けていない地域にも浸透しつつあります。

ヘルスケア政策と国際キャンペーンはどのように普及を加速させているか？

政府のヘルスケア政策と国際キャンペーンは、特に家族計画に対するニーズが満たされていない地域において、皮下避妊インプラントの採用を加速させる中心的な役割を果たしています。低・中所得諸国（LMICs）では、持続可能な開発目標（SDGs）のような枠組みの下で、リプロダクティブ・ヘルスケアへの普遍的アクセスを目指す動きが、避妊インプラントの大規模な調達と補助金配布に拍車をかけています。FP2030パートナーシップや世界のドナー連合などのイニシアチブは、メーカーとの有利な価格協定を確保し、インプラントが世界中の何百万人もの女性にとって手頃な価格か無料であることを保証しています。各国政府は、特にサハラ以南のアフリカと東南アジアにおいて、皮下インプラントを公衆衛生プログラムに組み入れ、地域保健ワーカーにトレーニングを提供し、アウトリーチと信頼を高めています。一方、先進諸国では、女性の健康、ジェンダー平等、生殖の自律をめぐる政策の転換により、LARCが保険適用となり、10代や若年成人の間で普及が進んでいます。学校や診療所を拠点とした啓発キャンペーンは、遠隔医療や薬局を拠点としたモデルによるアクセス拡大とともに、情報やサービスがより多くの人々に行き届くことを保証しています。このような政策とアドボカシーの協調的努力は、スティグマを減らし、アクセスを改善し、女性がリプロダクティブ・ヘルスについて十分な情報を得た上で選択できるようにしています。

技術革新はデバイスのデザインと受容性を高めているか？

インプラントのデザインと挿入方法における技術革新は、医療従事者と患者の双方にとって、より魅力的で安全かつ使いやすいものとなっています。市場では、より細く柔軟なロッドを持ち、挿入や抜去が容易で不快感の少ない次世代インプラントへのシフトが見られます。生体吸収性材料とホルモン放出機構の進歩により、エトノゲストレルのような活性薬剤をより一貫して制御された形で投与できるようになり、それによって有効性が向上し、副作用が減少しています。機器メーカーもまた、処置時間と複雑さを軽減するスマート挿入キットを開発しており、ヘルスケア提供者にこの方法を提供するようさらに促しています。マイクロチップやRFID（Radio-Frequency Identification）タグを組み込んで、投与情報を保存し、患者のフォローアップを容易にする、デジタルまたは追跡可能なインプラントに焦点を当てた研究も行われています。さらに、多様な社会文化的背景における受容性を向上させるため、文化的に配慮されたパッケージや説明資料が重視されるようになってきています。地域によっては抜去が引き続き懸念されるため、トレーニング・プログラムが挿入と安全かつ適時の抜去に等しく焦点を当てるよう努力が払われています。このような技術的進歩はすべて、器具をよりユーザー中心のものにし、それによって患者の満足度を高め、さまざまなヘルスケア・エコシステムにわたって市場範囲を拡大しています。

世界中でインプラントの需要が高まっている背景は？

皮下避妊インプラント市場の成長は、生殖医療の動向、ヘルスケアへのアクセス、人口動態の変化、医療技術革新に根ざしたいくつかの要因によって牽引されています。効果的でメンテナンスの少ない避妊に対する世界の需要の高まりは、特に毎日のアドヒアランスの課題なしに家族計画の自主性を求める女性の間で、大きな推進力となっています。都市部でも農村部でも、若年層が目立たない長期避妊ソリューションへの関心を高めており、インプラントはそのプロファイルによく合致しています。データや教育キャンペーンに裏付けされた、妊娠の遅延や間隔をあけることの健康的・経済的メリットに対する意識の高まりは、より多くの女性に長時間作用型の避妊法を選択するよう影響を与えています。さらに、政府やNGOが支援するリプロダクティブ・ヘルス・プログラムの普及により、より幅広い社会経済的グループにおいて、これらのインプラントがより利用しやすく、手頃な価格になってきています。ヘルスケア提供者の立場からすると、インプラントは、投与プロトコールが簡略化され、処置時間が短縮され、他の方法と比較してフォローアップの必要性が少ないため、現在支持されています。持続時間の延長、ホルモン投与の改善、取り外しの容易さなど、器具自体の技術的改良が消費者の信頼を高めています。世界中の規制機関も、新しいモデルの承認と採用を急ピッチで進めており、その公衆衛生上の価値を認めています。最後に、家族計画に対する文化的な考え方の変化や、教育や労働力への女性の参加の増加により、生殖に関する自律性の重要性が強化され、皮下インプラントは現代の避妊ケアにおいて説得力のあるソリューションとなっています。

セグメント

製品（エトノゲストレルインプラント、レボノルゲストレルインプラント）、流通チャネル（病院、婦人科クリニック、地域医療センター、その他）

調査対象企業の例

  • Allergan plc
  • Baxter International Inc.
  • Bayer AG
  • Bayer Schering Pharma
  • Conceptus Inc.
  • Contraline, Inc.
  • DKT International
  • DKT WomanCare
  • Eli Lilly and Company
  • FHI 360
  • Gerresheimer AG
  • HRA Pharma
  • Karex Industries
  • KESSEL medintim GmbH
  • Leiras Oy
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Organon
  • Pfizer Inc.
  • Population Council
  • Reckitt Benckiser Group plc
  • Sandoz International GmbH
  • Schott AG
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company
  • Theramex
  • Wyeth Pharmaceuticals

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP33069

Global Subdermal Contraceptive Implants Market to Reach US$1.6 Billion by 2030

The global market for Subdermal Contraceptive Implants estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Etonogestrel Implant, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Levonorgestrel Implant segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$296.0 Million While China is Forecast to Grow at 10.8% CAGR

The Subdermal Contraceptive Implants market in the U.S. is estimated at US$296.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$337.7 Million by the year 2030 trailing a CAGR of 10.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Subdermal Contraceptive Implants Market - Key Trends & Drivers Summarized

Why Are Subdermal Implants Gaining Favor Over Traditional Contraceptives?

Subdermal contraceptive implants are witnessing a notable surge in global adoption, largely due to the growing preference for long-acting reversible contraceptives (LARCs) among women of reproductive age. Unlike daily oral contraceptives or short-term methods like patches and injections, subdermal implants offer protection for three to five years with a single insertion, significantly reducing the risk of user error and increasing overall efficacy. The market is benefitting from increased awareness and education about reproductive rights and contraception options, particularly in developing regions where access to healthcare is improving. Furthermore, public health initiatives by organizations such as the World Health Organization (WHO), UNFPA, and USAID are actively promoting the use of implants in regions with high fertility rates and limited access to contraceptive resources. Compared to intrauterine devices (IUDs), subdermal implants are less invasive and do not require uterine placement, making them a preferred option for women who may not have given birth. The minimal maintenance, discreet nature, and reversible function of implants are reshaping how contraception is viewed, shifting the narrative toward convenience, autonomy, and long-term planning. As a result, these devices are not only finding favor in urban, educated populations but also penetrating rural and underserved areas via government and NGO-supported programs.

How Are Healthcare Policies and Global Campaigns Accelerating Adoption?

Government healthcare policies and international campaigns are playing a central role in accelerating the adoption of subdermal contraceptive implants, especially in regions with unmet needs for family planning. In low- and middle-income countries (LMICs), the push toward universal access to reproductive healthcare under frameworks like the Sustainable Development Goals (SDGs) has spurred large-scale procurement and subsidized distribution of contraceptive implants. Initiatives such as the FP2030 partnership and global donor alliances have secured favorable pricing agreements with manufacturers, ensuring implants are affordable or free to millions of women worldwide. National governments, particularly in Sub-Saharan Africa and Southeast Asia, are integrating subdermal implants into public health programs and providing training for community health workers to increase outreach and trust. Meanwhile, in developed countries, policy shifts around women's health, gender equity, and reproductive autonomy have led to insurance coverage for LARCs, boosting their uptake among teenagers and young adults. School-based and clinic-based awareness campaigns, alongside expanding access via telehealth and pharmacy-based models, are ensuring that information and services reach broader populations. These coordinated policy and advocacy efforts are reducing stigma, improving access, and ensuring that women can make informed choices about their reproductive health-factors that are directly driving growth in the subdermal contraceptive implant market.

Are Technological Innovations Enhancing Device Design and Acceptance?

Yes, technological innovations in implant design and insertion methods are making subdermal contraceptive implants more appealing, safer, and easier to use for both healthcare providers and patients. The market is seeing a shift toward next-generation implants with thinner, more flexible rods that are easier to insert and remove with minimal discomfort. Advancements in bioresorbable materials and hormone release mechanisms are allowing for more consistent and controlled delivery of active agents like etonogestrel, thereby improving efficacy and reducing side effects. Device manufacturers are also developing smart insertion kits that reduce procedural time and complexity, further encouraging healthcare providers to offer the method. Some research efforts are focused on digital or trackable implants, incorporating microchips or radio-frequency identification (RFID) tags that can store dosing information and facilitate patient follow-up. Additionally, there’s an increased emphasis on culturally sensitive packaging and instruction materials, improving acceptance in diverse sociocultural contexts. As removal continues to be a concern in some regions, efforts are being made to ensure training programs focus equally on insertion and safe, timely removal. All these technological strides are making the devices more user-centric, thereby enhancing patient satisfaction and expanding market reach across different healthcare ecosystems.

What’s Behind the Rising Demand for These Implants Around the World?

The growth in the subdermal contraceptive implants market is driven by several factors rooted in reproductive health trends, healthcare access, demographic shifts, and medical innovation. The rising global demand for effective, low-maintenance contraception is a major driver, particularly among women seeking autonomy in family planning without daily adherence challenges. Younger populations in both urban and rural areas are showing increased interest in discreet, long-term contraceptive solutions, and implants fit that profile well. Growing awareness of the health and economic benefits of delayed or spaced pregnancies, supported by data and educational campaigns, is influencing more women to choose long-acting methods. Furthermore, the proliferation of government and NGO-supported reproductive health programs is making these implants more accessible and affordable across a wider range of socioeconomic groups. From a healthcare provider standpoint, implants are now favored due to simplified administration protocols, shorter procedure times, and fewer follow-up requirements compared to alternatives. Technological refinement in the devices themselves-such as longer duration, improved hormone delivery, and easier removability-is reinforcing consumer trust. Regulatory bodies worldwide are also fast-tracking approval and adoption of new models, recognizing their public health value. Lastly, shifting cultural attitudes toward family planning and increased female participation in education and the workforce are reinforcing the importance of reproductive autonomy, making subdermal implants a compelling solution in modern contraceptive care.

SCOPE OF STUDY:

The report analyzes the Subdermal Contraceptive Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Etonogestrel Implant, Levonorgestrel Implant); Distribution Channel (Hospital, Gynecology Clinics, Community Health Care Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Allergan plc
  • Baxter International Inc.
  • Bayer AG
  • Bayer Schering Pharma
  • Conceptus Inc.
  • Contraline, Inc.
  • DKT International
  • DKT WomanCare
  • Eli Lilly and Company
  • FHI 360
  • Gerresheimer AG
  • HRA Pharma
  • Karex Industries
  • KESSEL medintim GmbH
  • Leiras Oy
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Novartis AG
  • Organon
  • Pfizer Inc.
  • Population Council
  • Reckitt Benckiser Group plc
  • Sandoz International GmbH
  • Schott AG
  • Shanghai Dahua Pharmaceutical Co., Ltd.
  • SMB Corporation
  • Teva Pharmaceutical Industries Ltd.
  • The Female Health Company
  • Theramex
  • Wyeth Pharmaceuticals

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Subdermal Contraceptive Implants - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Focus on Long-Acting Reversible Contraceptives (LARCs) Propels Growth in Subdermal Implant Adoption
    • Increased Government and NGO-Led Family Planning Initiatives Expand the Addressable Market in Emerging Economies
    • Shift Toward Female-Centric and Autonomous Contraceptive Methods Strengthens the Business Case for Implants
    • Affordability and High Efficacy of Subdermal Implants Drive Demand in Public Health and Low-Income Settings
    • Growing Acceptance of Minimal-Maintenance Birth Control Solutions Accelerates Demand Across Age Groups
    • Technological Advancements in Implant Materials and Insertion Devices Spur Innovation and Safety Improvements
    • Healthcare Provider Training and Outreach Programs Drive Adoption in Underserved and Rural Populations
    • Changing Social Norms and Awareness Campaigns Generate Demand for Discreet and Long-Term Contraception
    • Rising Insurance Coverage and Reimbursement Support Strengthens Uptake in Developed Markets
    • Expanded Use in Postpartum and Adolescent Contraception Creates New Opportunities for Market Penetration
    • Demand for Reversible and Fertility-Preserving Options Spurs Preference for Implantable Devices
    • Integration of Contraceptive Counseling into Primary Healthcare Systems Supports Long-Term Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Subdermal Contraceptive Implants Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Subdermal Contraceptive Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Etonogestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Etonogestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Etonogestrel Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Levonorgestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Levonorgestrel Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Levonorgestrel Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gynecology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gynecology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Gynecology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Community Health Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Community Health Care Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Community Health Care Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • JAPAN
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • CHINA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • EUROPE
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Subdermal Contraceptive Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • FRANCE
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • GERMANY
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • INDIA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Subdermal Contraceptive Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Subdermal Contraceptive Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030
  • AFRICA
    • Subdermal Contraceptive Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Subdermal Contraceptive Implants by Product - Etonogestrel Implant and Levonorgestrel Implant Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Subdermal Contraceptive Implants by Product - Percentage Breakdown of Value Sales for Etonogestrel Implant and Levonorgestrel Implant for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Subdermal Contraceptive Implants by Distribution Channel - Hospital, Gynecology Clinics, Community Health Care Centers and Others Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Subdermal Contraceptive Implants by Distribution Channel - Percentage Breakdown of Value Sales for Hospital, Gynecology Clinics, Community Health Care Centers and Others for the Years 2015, 2025 & 2030

IV. COMPETITION